Human amniotic epithelial stem cells(Shanghai Icell Biotechnology)
人羊膜上皮干细胞（上海赛傲生物技术）
Report date: 2026/04/17 20:02:02
Base Information
Drug NameHuman amniotic epithelial stem cells(Shanghai Icell Biotechnology)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Icell Biotechnology Co., Ltd, Shanghai, China
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesShanghai Icell Biotechnology Co., Ltd, Shanghai, China
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A